S Squared Technology LLC grew its holdings in shares of DocGo Inc. (NASDAQ:DCGO - Free Report) by 36.8% during the first quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 1,890,976 shares of the company's stock after purchasing an additional 508,590 shares during the quarter. DocGo comprises about 2.6% of S Squared Technology LLC's investment portfolio, making the stock its 15th biggest position. S Squared Technology LLC owned approximately 1.85% of DocGo worth $4,992,000 at the end of the most recent quarter.
A number of other hedge funds and other institutional investors have also modified their holdings of DCGO. Punch & Associates Investment Management Inc. grew its stake in DocGo by 17.4% in the 1st quarter. Punch & Associates Investment Management Inc. now owns 2,201,667 shares of the company's stock valued at $5,812,000 after buying an additional 325,760 shares during the last quarter. AQR Capital Management LLC grew its stake in DocGo by 219.1% in the 1st quarter. AQR Capital Management LLC now owns 476,645 shares of the company's stock valued at $1,258,000 after buying an additional 327,269 shares during the last quarter. Birchview Capital LP grew its stake in DocGo by 13.1% in the 1st quarter. Birchview Capital LP now owns 864,062 shares of the company's stock valued at $2,281,000 after buying an additional 100,000 shares during the last quarter. Penn Capital Management Company LLC grew its stake in DocGo by 257.8% in the 1st quarter. Penn Capital Management Company LLC now owns 48,774 shares of the company's stock valued at $129,000 after buying an additional 35,142 shares during the last quarter. Finally, Summit Securities Group LLC acquired a new position in DocGo in the 1st quarter valued at $34,000. Institutional investors own 56.44% of the company's stock.
DocGo Stock Down 2.5%
NASDAQ DCGO traded down $0.04 during midday trading on Friday, hitting $1.53. The company had a trading volume of 421,979 shares, compared to its average volume of 315,605. The stock has a market cap of $149.65 million, a price-to-earnings ratio of -8.05 and a beta of 0.97. The firm has a fifty day simple moving average of $1.53 and a two-hundred day simple moving average of $1.90. DocGo Inc. has a fifty-two week low of $1.23 and a fifty-two week high of $5.68.
DocGo (NASDAQ:DCGO - Get Free Report) last posted its quarterly earnings results on Thursday, August 7th. The company reported ($0.11) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.06) by ($0.05). The company had revenue of $80.42 million during the quarter, compared to analyst estimates of $77.58 million. DocGo had a negative return on equity of 3.26% and a negative net margin of 4.20%. DocGo has set its FY 2025 guidance at EPS. As a group, equities analysts predict that DocGo Inc. will post 0.25 earnings per share for the current year.
Wall Street Analysts Forecast Growth
Separately, Canaccord Genuity Group raised their target price on shares of DocGo from $1.45 to $1.60 and gave the company a "hold" rating in a research note on Thursday, August 21st. Three research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company's stock. According to data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and an average price target of $3.59.
Read Our Latest Research Report on DocGo
DocGo Profile
(
Free Report)
DocGo Inc provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services.
Featured Stories

Before you consider DocGo, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DocGo wasn't on the list.
While DocGo currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.